The erythroid variant of CML is distinguished by the presence of t(9;22) (q34;q11.2) BCR::ABL1 in predominant erythroid precursors at different stages of maturation. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.